Literature DB >> 27019658

Integrative network modeling approaches to personalized cancer medicine.

Brian A Kidd1, Ben P Readhead1, Caroline Eden2, Samir Parekh2, Joel T Dudley3.   

Abstract

The ability to collect millions of molecular measurements from patients is a now a reality for clinical medicine. This reality has created the challenge of how to integrate these vast amounts of data into models that accurately predict complex pathophysiology and can translate this complexity into clinically actionable outputs. Integrative informatics and data-driven approaches provide a framework for analyzing large-scale datasets and combining them into multiscale models that can be used to determine the key drivers of disease and identify optimal therapies for treating tumors. In this perspective we discuss how an integrative modeling approach is being used to inform individual treatment decisions, highlighting a recent case report that illustrates the challenges and opportunities for personalized oncology.

Entities:  

Keywords:  drug repositioning; genomics; multiple myeloma; multiscale modeling; networks; personalized medicine

Year:  2015        PMID: 27019658      PMCID: PMC4806849          DOI: 10.2217/pme.14.87

Source DB:  PubMed          Journal:  Per Med        ISSN: 1741-0541            Impact factor:   2.512


  91 in total

1.  The path to personalized medicine.

Authors:  Margaret A Hamburg; Francis S Collins
Journal:  N Engl J Med       Date:  2010-06-15       Impact factor: 91.245

2.  An integrative genomics approach to infer causal associations between gene expression and disease.

Authors:  Eric E Schadt; John Lamb; Xia Yang; Jun Zhu; Steve Edwards; Debraj Guhathakurta; Solveig K Sieberts; Stephanie Monks; Marc Reitman; Chunsheng Zhang; Pek Yee Lum; Amy Leonardson; Rolf Thieringer; Joseph M Metzger; Liming Yang; John Castle; Haoyuan Zhu; Shera F Kash; Thomas A Drake; Alan Sachs; Aldons J Lusis
Journal:  Nat Genet       Date:  2005-06-19       Impact factor: 38.330

Review 3.  Molecular networks as sensors and drivers of common human diseases.

Authors:  Eric E Schadt
Journal:  Nature       Date:  2009-09-10       Impact factor: 49.962

4.  Comparative analysis between azacitidine and decitabine for the treatment of myelodysplastic syndromes.

Authors:  Yun-Gyoo Lee; Inho Kim; Sung-Soo Yoon; Seonyang Park; June Won Cheong; Yoo Hong Min; Jeong-Ok Lee; Soo-Mee Bang; Hyeon Gyu Yi; Chul Soo Kim; Yong Park; Byung-Soo Kim; Yeung-Chul Mun; Chu-Myoung Seong; Jinny Park; Jae Hoon Lee; Sung-Yong Kim; Hong Ghi Lee; Yeo-Kyeoung Kim; Hyeoung-Joon Kim
Journal:  Br J Haematol       Date:  2013-02-21       Impact factor: 6.998

5.  Overlap and effective size of the human CD8+ T cell receptor repertoire.

Authors:  Harlan S Robins; Santosh K Srivastava; Paulo V Campregher; Cameron J Turtle; Jessica Andriesen; Stanley R Riddell; Christopher S Carlson; Edus H Warren
Journal:  Sci Transl Med       Date:  2010-09-01       Impact factor: 17.956

6.  DNMT3A mutations in acute myeloid leukemia.

Authors:  Timothy J Ley; Li Ding; Matthew J Walter; Michael D McLellan; Tamara Lamprecht; David E Larson; Cyriac Kandoth; Jacqueline E Payton; Jack Baty; John Welch; Christopher C Harris; Cheryl F Lichti; R Reid Townsend; Robert S Fulton; David J Dooling; Daniel C Koboldt; Heather Schmidt; Qunyuan Zhang; John R Osborne; Ling Lin; Michelle O'Laughlin; Joshua F McMichael; Kim D Delehaunty; Sean D McGrath; Lucinda A Fulton; Vincent J Magrini; Tammi L Vickery; Jasreet Hundal; Lisa L Cook; Joshua J Conyers; Gary W Swift; Jerry P Reed; Patricia A Alldredge; Todd Wylie; Jason Walker; Joelle Kalicki; Mark A Watson; Sharon Heath; William D Shannon; Nobish Varghese; Rakesh Nagarajan; Peter Westervelt; Michael H Tomasson; Daniel C Link; Timothy A Graubert; John F DiPersio; Elaine R Mardis; Richard K Wilson
Journal:  N Engl J Med       Date:  2010-11-10       Impact factor: 91.245

7.  Multiplexed ion beam imaging of human breast tumors.

Authors:  Michael Angelo; Sean C Bendall; Rachel Finck; Matthew B Hale; Chuck Hitzman; Alexander D Borowsky; Richard M Levenson; John B Lowe; Scot D Liu; Shuchun Zhao; Yasodha Natkunam; Garry P Nolan
Journal:  Nat Med       Date:  2014-03-02       Impact factor: 53.440

8.  Screening for epidermal growth factor receptor mutations in lung cancer.

Authors:  Rafael Rosell; Teresa Moran; Cristina Queralt; Rut Porta; Felipe Cardenal; Carlos Camps; Margarita Majem; Guillermo Lopez-Vivanco; Dolores Isla; Mariano Provencio; Amelia Insa; Bartomeu Massuti; Jose Luis Gonzalez-Larriba; Luis Paz-Ares; Isabel Bover; Rosario Garcia-Campelo; Miguel Angel Moreno; Silvia Catot; Christian Rolfo; Noemi Reguart; Ramon Palmero; José Miguel Sánchez; Roman Bastus; Clara Mayo; Jordi Bertran-Alamillo; Miguel Angel Molina; Jose Javier Sanchez; Miquel Taron
Journal:  N Engl J Med       Date:  2009-08-19       Impact factor: 91.245

9.  The effect of azacitidine on interleukin-6 signaling and nuclear factor-kappaB activation and its in vitro and in vivo activity against multiple myeloma.

Authors:  Tiffany Khong; Janelle Sharkey; Andrew Spencer
Journal:  Haematologica       Date:  2008-04-28       Impact factor: 9.941

Review 10.  RNA-Seq: a revolutionary tool for transcriptomics.

Authors:  Zhong Wang; Mark Gerstein; Michael Snyder
Journal:  Nat Rev Genet       Date:  2009-01       Impact factor: 53.242

View more
  6 in total

Review 1.  Overcoming multiple myeloma drug resistance in the era of cancer 'omics'.

Authors:  Matthew Ho Zhi Guang; Amanda McCann; Giada Bianchi; Li Zhang; Paul Dowling; Despina Bazou; Peter O'Gorman; Kenneth C Anderson
Journal:  Leuk Lymphoma       Date:  2017-06-13

Review 2.  Adenosine Metabolism: Emerging Concepts for Cancer Therapy.

Authors:  Detlev Boison; Gennady G Yegutkin
Journal:  Cancer Cell       Date:  2019-12-09       Impact factor: 31.743

3.  Cancer Immunotherapy and Personalized Medicine: Emerging Technologies and Biomarker-Based Approaches.

Authors:  Laura Maciejko; Munisha Smalley; Aaron Goldman
Journal:  J Mol Biomark Diagn       Date:  2017-06-28

Review 4.  Network-based machine learning and graph theory algorithms for precision oncology.

Authors:  Wei Zhang; Jeremy Chien; Jeongsik Yong; Rui Kuang
Journal:  NPJ Precis Oncol       Date:  2017-08-08

5.  Systematic analyses of drugs and disease indications in RepurposeDB reveal pharmacological, biological and epidemiological factors influencing drug repositioning.

Authors:  Khader Shameer; Benjamin S Glicksberg; Rachel Hodos; Kipp W Johnson; Marcus A Badgeley; Ben Readhead; Max S Tomlinson; Timothy O'Connor; Riccardo Miotto; Brian A Kidd; Rong Chen; Avi Ma'ayan; Joel T Dudley
Journal:  Brief Bioinform       Date:  2018-07-20       Impact factor: 11.622

Review 6.  AI in Health: State of the Art, Challenges, and Future Directions.

Authors:  Fei Wang; Anita Preininger
Journal:  Yearb Med Inform       Date:  2019-08-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.